The modulation of the gut microbiome has attracted recent interest and we are progressively developing a deeper understanding of the role of microbiota-derived components in human diseases. 1,2
Studies have shown strong evidence that bacterial viability is not essential for imparting health benefits and the term ‘postbiotic’ was created to denote this concept.
ISAPP has recently published a consensus on postbiotics describing them as a “preparation of inanimate microorganisms and/or their components that confers a health benefit on the host”. 3
The ISAPP consensus specifies that viruses (including bacteriophages), vaccines, filtrates without cell components and purified microbial components and metabolites are not classed as postbiotics.
Postbiotics in practice
The positive health impact of postbiotics must be confirmed in the target host which could be either human or animal. The consensus also highlights that, although the gut is not their only site of action, postbiotics must be administered to a host surface such as the oral cavity, gut, skin, urogenital tract or nasopharynx. Injections are outside the scope of postbiotics.
Safety, efficacy & convenience compared to live microorganisms
Postbiotics are available as prescription or over-the-counter medications and also as food supplements. Postbiotics are already being used for several therapeutic purposes in humans: for example, Lactobacillus LB and its culture medium are indicated for the treatment of acute, antibiotic-related and chronic diarrhea. Several other indications could benefit from postbiotics showing that they can play a valuable role in clinical practice.
Postbiotic efficacy across a range of indications in adults
|Helicobacter pylori-positive infection (dyspepsia)||Heat-treated Lactobacillus LB plus fermented culture medium||Eradication rates: Triple therapy alone - 72% Triple therapy plus inactivated Lactobacillus LB – 87% (p=.02)|
|Irritable Bowel Syndrome with diarrhea (IBS-D)||Heat-treated Lactobacillus LB plus fermented culture medium||Improved scores for pain, bloating, diarrhea and quality of life|
|Irritable Bowel Syndrome||Bifidobacterium bifidum||Composite primary endpoint of ≥ 30% improvement in pain and adequate relief of overall IBS symptoms in at least 4 of 8 weeks of treatment. Primary endpoint achieved in 34% active vs. 19% placebo.|
|Chronic diarrhea||Heat-treated Lactobacillus LB plus fermented culture medium||Reduced stool frequency at weeks 2 and 4; overall symptoms improved at 4 weeks in heat-treated Lactobacillus LB group|
|Obstructive jaundice||Lactobacillus plantarum||Measured intestinal permeability – increased in water in inactivated groups; trend towards normalization in active group|
|Stress response||Lactobacillus gasseri||In male students sleep quality was improved and diarrhea prevented. Not in females|
|Chronic stress response||Lactobacillus gasseri||Significant reduction in anxiety and sleep disturbance. Accompanied by EEG changes, reduction in salivary chromogranin and resolution of stress-related microbiota changes|
|Latent tuberculosis||Mycobacterium manresensis||Increased regulatory T-cell response; well tolerated|
|Moderate, persistent asthma||Mycobacterium phlei||Symptom scores and spirometry improved|
|Severe chronic obstructive pulmonary disease (COPD)||Haemophilus influenzae||Reduced severe exacerbations by 63% and exacerbations requiring corticosteroid therapy by 56% and hospitalization by 90%|
Postbiotic efficacy across a range of indications in children
|Acute Gastritis||Heat-treated Lactobacillus LB plus fermented culture medium||Results of meta-analysis showed that heat-treated Lactobacillus LB reduced duration of diarrhea in hospitalised, children compared with placebo|
|Acute rotavirus diarrhea||
|Equivalent clinical recovery versus viable L.casei Lactobacillus LB was significantly more effective than placebo|
|Prevention of infectious disease||Lactobacillus paracasei||Reduced risk of common infections such as gastroenteritis and respiratory tract infections|
|Allergic rhinitis||Lactobacillus paracasei||Improvement in overall quality of life. Equivalent results to those obtained with viable L.paracasei|
1 Zolkiewicz et al., Postbiotics—A Step Beyond Pre- and Probiotics. Nutrients (2020). 2 Puccetti et al., Postbiotic-Enabled Targeting of the Host-Microbiota-Pathogen Interface: Hints of Antibiotic Decline? Pharmaceuticals (2020). 3 Salminen, S., Collado, M.C., Endo, A. et al. The International Scientific Association of Probiotics and Prebiotics (ISAPP) consensus statement on the definition and scope of postbiotics. Nat Rev Gastroenterol Hepatol (2021). https://doi.org/10.1038/s41575-021-00440-6. 4 Belinda Vallejo-Cordoba et al., Postbiotics and paraprobiotics: A review of current evidence and emerging trends. Advances in Food and Nutrition Research (2020). 5 Piqué N. et al. Health Benefits of Heat-Killed (Tyndallized) Probiotics: An Overview. International Journal of Molecular Sciences 2019;20(10).
Experts talk about postbiotics
Discover what our experts say about postbiotics: their definition, benefits over other biotics, and demonstrated health benefits of postbiotics.
What is a postbiotic?
Hear from Professor Colin Hill the reasons why postbiotics are going to be the biotics of the future.
Over the past decade, the term ‘postbiotic’ has appeared quite often in scientific literature in reference to various microorganism-derived preparations used to promote health. This year, the 2021 Consensus issued by the International Scientific Association of Probiotics and Prebiotics (ISAPP) provided a clear definition of a postbiotic.
What are the benefits of postbiotics over living biotics?
In this video, Professor Sarah Lebeer tells us more about the advantages of postbiotics over living biotics and about the five main mechanisms of actions that have been identified for postbiotics.
Postbiotics are inanimate but certainly not inactive. They can modulate, protect and promote multiple functions, while offering several advantages over living microorganisms.
What’s the evidence of human health benefits from postbiotics?
Professor Gabriel Vinderola explains the benefits of postbiotics for both children and adults.
A lot of research has been carried out on postbiotics that includes in vitro, animal and clinical studies. In humans, postbiotics have been shown to reduce the risk of infection and allergic diseases as well as treating gastrointestinal pathologies amongst others.